UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,954,807
+$436,394 QoQ
Shares Held
280,889
+0.6% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. CPRX ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,954,807 | 280,889 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,518,413 | 279,281 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,462,826 | 277,301 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $12,709,058 | 585,671 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,762,699 | 526,297 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,507,694 | 263,905 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,696,091 | 236,222 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,889,845 | 251,120 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,844,957 | 115,744 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,941,368 | 115,489 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,350,064 | 115,489 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,842,312 | 137,077 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,272,735 | 137,077 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,361,287 | 126,951 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,554,186 | 121,137 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $854,994 | 121,968 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,042,533 | 125,758 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,114,733 | 164,658 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $729,676 | 137,675 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,164,230 | 202,475 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $898,954 | 195,001 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $651,303 | 195,001 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $288,983 | 97,301 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $462,706 | 100,153 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $387,474 | 100,643 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||